PEBP1 and melanoma: Moreover, some potential non-invasive biomarkers in sera could be used to predict the metastasis and prognosis of melanoma, and miR-23a has been reported to suppress the expression of raf kinase inhibitor protein (RKIP), which was a metastasis inhibitor and inversely correlated with metastases in UM (27–29).